A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer (HER2CLIMB)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/151/1/21

Funding

  • Cascadian Therapeutics